Does semaglutide cause dangerous surgical complications?

What's this video probably claiming?

Based on the caption, hashtags like #homeopathic and #allnatural, and the creator handle (@krystaw_skinny.drops), this video is almost certainly using a single anecdote about a prolonged surgical recovery to argue that GLP-1 receptor agonists like semaglutide are dangerously underreported for side effects. The implicit counter-pitch is likely toward "natural" or homeopathic alternatives for weight loss. The caption references someone undergoing surgery at 10am and not waking from recovery until 5:30pm, framing this as a GLP-1 complication. The creator appears to be building an emotional case that these medications are reckless, using fear and a dramatic story to drive that point. That framing deserves serious scrutiny, because surgical complications involving GLP-1 users are a real but nuanced clinical topic, and conflating anecdote with established risk profile is a reliable way to mislead people who are genuinely trying to make informed decisions.

What does the science actually show?

There is one legitimate and well-documented surgical concern with GLP-1 receptor agonists: delayed gastric emptying. Semaglutide slows gastric motility, which raises the risk of aspiration under anesthesia if patients haven't adequately fasted. The American Society of Anesthesiologists issued a consensus statement in 2023 recommending that patients on daily GLP-1 therapy hold the medication the day prior to procedures, and that weekly injectables like semaglutide be held one full week before elective surgery. A 2023 case series published in Anaesthesia (Silveira et al.) documented retained gastric contents in GLP-1 users despite standard nil-by-mouth protocols. This is a real, manageable risk, not a reason to panic. The solution is proper pre-operative communication between patients and providers, not abandoning a medication class that produced 14.9% mean body weight reduction at 68 weeks in the SUSTAIN-6 trial (Marso et al., 2016, NEJM). The risk is procedural, not inherent to taking the drug.

Where does the social media noise diverge from clinical reality?

The gap here is significant. A lengthy recovery room stay has dozens of plausible explanations: anesthesia sensitivity, the procedure itself, post-operative pain management protocols, or yes, a GLP-1-related aspiration issue. One video cannot establish causation, and this creator isn't attempting to. They're using emotional framing and a vague story to build distrust. The hashtags are the tell. #Homeopathic and #plantbased signal an alternative product pitch is either in this video or coming. Homeopathic weight loss products have zero clinical evidence behind them. Zero. The irony is sharp: a creator warning about risks from a medication with a documented safety profile monitored across thousands of trial participants is pivoting toward products with no safety data at all. The SCALE trial (Pi-Sunyer et al., 2015, NEJM) on liraglutide and the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) on tirzepatide both included rigorous adverse event tracking. No homeopathic "skinny drop" product can say the same.

What should you actually know?

If you're on semaglutide or any GLP-1 medication and you have an upcoming procedure, tell your anesthesiologist and surgeon. The ASA 2023 guidance is clear: hold weekly semaglutide for seven days before elective surgery and consider a liquid diet in the 24 hours prior. This is a manageable protocol, not a condemnation of the drug. Side effects from GLP-1 therapy are real and documented: nausea affects roughly 44% of semaglutide users in trials, vomiting around 24%, and there are rare but serious risks including pancreatitis and gallbladder disease that warrant monitoring. These are reasons to use the medication under medical supervision, not reasons to replace it with unregulated drops. Anyone telling you that a homeopathic product is a safer alternative to a clinically-studied medication has the burden of proof entirely backward. The anecdote in this caption is being used as evidence it cannot carry.